University of Würzburg-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2023

  1. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine

    European Journal of Nuclear Medicine and Molecular Imaging

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2020

  1. EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours

    EJNMMI Physics, Vol. 7, Núm. 1

2019

  1. Patient-Reported Outcomes–Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression

    International Journal of Radiation Oncology Biology Physics, Vol. 105, Núm. 4, pp. 760-764

2018

  1. Comparison of two radiotherapy regimens for metastatic spinal cord compression: Subgroup analyses from a randomized trial

    Anticancer Research, Vol. 38, Núm. 2, pp. 1009-1015

2017

  1. 131I activity quantification of gamma camera planar images

    Physics in Medicine and Biology, Vol. 62, Núm. 3, pp. 909-926

  2. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

    Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778

  3. Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5×4 Gy for metastatic epidural spinal cord compression

    Practical Radiation Oncology, Vol. 7, Núm. 2, pp. 137-144

  4. Role of the overall treatment time of radiotherapy with 10 × 3 Gy for outcomes in patients with metastatic spinal cord compression

    Journal of Medical Imaging and Radiation Oncology, Vol. 61, Núm. 3, pp. 388-393

2016

  1. Radiotherapy with 4 Gy × 5 versus 3 Gy × 10 for metastatic epidural spinal cord compression: Final results of the SCORE-2 Trial (ARO 2009/01)

    Journal of Clinical Oncology, Vol. 34, Núm. 6, pp. 597-602

2015

  1. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

    JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361

2012

  1. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2

    European Journal of Human Genetics, Vol. 20, Núm. 12, pp. 1203-1208

  2. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

    Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 645-657

  3. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

    Human Mutation, Vol. 33, Núm. 4, pp. 690-702

2010

  1. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

    Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754